(Q34235739)

English

CpG oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

CpG oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Lin Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chunhong Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Zhenke Wen

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ya Zhou

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Zhongmin Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yongjie Liang

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Zengguang Xu

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tao Ren

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

20 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Clinical and Developmental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

410893

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Th17 cells: positive or negative role in tumor?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

T(H)17 cells in tumour immunity and immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Protumor vs antitumor functions of IL-17.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

The IL-17/IL-23 axis of inflammation in cancer: friend or foe?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Endogenous IL-17 contributes to reduced tumor growth and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

CpG oligodeoxynucleotide-based therapy of lymphoid malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Tumor-specific Th17-polarized cells eradicate large established melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

IL-23 promotes tumour incidence and growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Adoptive-cell-transfer therapy for the treatment of patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2963116

28 July 2018

Chimeric antigen receptor-engineered T cells for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F410893

21 January 2018

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F410893

21 January 2018

Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F410893

21 January 2018

Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F410893

21 January 2018

Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F410893

21 January 2018

Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The role of Th17 cells in anti-cancer immunity]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of CD4(+)CD25(high) regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2010/410893

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34235739&oldid=1981136208"